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The giant protein titin performs structure-preserving functions in the sarcomere and
is important for the passive stiffness (Fpassive) of cardiomyocytes. Protein kinase D
(PKD) enzymes play crucial roles in regulating myocardial contraction, hypertrophy, and
remodeling. PKD phosphorylates myofilament proteins, but it is not known whether
the giant protein titin is also a PKD substrate. Here, we aimed to determine whether
PKD phosphorylates titin and thereby modulates cardiomyocyte Fpassive in normal and
failing myocardium. The phosphorylation of titin was assessed in cardiomyocyte-specific
PKD knock-out mice (cKO) and human hearts using immunoblotting with a
phosphoserine/threonine and a phosphosite-specific titin antibody. PKD-dependent
site-specific titin phosphorylation in vivo was quantified by mass spectrometry using
stable isotope labeling by amino acids in cell culture (SILAC) of SILAC-labeled mouse
heart protein lysates that were mixed with lysates isolated from hearts of either
wild-type control (WT) or cKO mice. Fpassive of single permeabilized cardiomyocytes
was recorded before and after PKD and HSP27 administration. All-titin phosphorylation
was reduced in cKO compared to WT hearts. Multiple conserved PKD-dependent
phosphosites were identified within the Z-disk, A-band and M-band regions of titin
by quantitative mass spectrometry, and many PKD-dependent phosphosites detected
in the elastic titin I-band region were significantly decreased in cKO. Analysis of
titin site-specific phosphorylation showed unaltered or upregulated phosphorylation
in cKO compared to matched WT hearts. Fpassive was elevated in cKO compared
to WT cardiomyocytes and PKD administration lowered Fpassive of WT and cKO
cardiomyocytes. Cardiomyocytes from hypertrophic cardiomyopathy (HCM) patients
showed higher Fpassive compared to control hearts and significantly lower Fpassive after
PKD treatment. In addition, we found higher phosphorylation at CaMKII-dependent titin
sites in HCM compared to control hearts. Expression and phosphorylation of HSP27,
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a substrate of PKD, were elevated in HCM hearts, which was associated with increased
PKD expression and phosphorylation. The relocalization of HSP27 in HCM away from
the sarcomeric Z-disk and I-band suggested that HSP27 failed to exert its protective
action on titin extensibility. This protection could, however, be restored by administration
of HSP27, which significantly reduced Fpassive in HCM cardiomyocytes. These findings
establish a previously unknown role for PKDin regulating diastolic passive properties of
healthy and diseased hearts.
Keywords: titin, HCM, PKD, Hsp27, stiffness
INTRODUCTION
Protein kinase (PK)D is a serine/threonine kinase that belongs to
the family of calcium/calmodulin-dependent kinases (CaMKII)
due to its catalytic domain structure and substrate specificity. The
PKD kinase family consists of three members: PKD1 (formerly
known as PKCµ) (Valverde et al., 1994) and the predominant
isoforms in the heart (Sin and Baillie, 2012), PKD2 (Sturany et al.,
2001), and PKD3 (also known as PKCν) (Hayashi et al., 1999).
The isoforms differ in structural and enzymatic properties from
members of the PKC family. Some substrates that are targets
of PKC are not phosphorylated by PKD (Johannes et al., 1994;
Valverde et al., 1994; Van Lint et al., 1995), and unlike CaMKII,
PKD is not directly activated by Ca2+ or calmodulin (Avkiran
et al., 2008).
PKD can be activated by other stimuli including reactive
oxygen species (ROS), growth factors (i.e., platelet-derived
growth factor), and triggering of immune cell receptors. The PKD
kinase is involved in the regulation of myocardial contraction
by phosphorylating cardiac myosin binding protein C (cMyBP-
C), cardiac troponin I (cTnI) and the L-type, voltage gated
Ca2+ channel (Haworth et al., 2004; Cuello et al., 2007; Aita
et al., 2011; Dirkx et al., 2012). Phosphorylation of TnI by
PKD resulted in a significant rightward shift of the tension–pCa
relationship, indicating reduced myofilament Ca2+ sensitivity
(Haworth et al., 2004; Cuello et al., 2007; Aita et al., 2011; Dirkx
et al., 2012). At submaximal Ca2+ activation, PKD-mediated
phosphorylation also accelerated isometric cross-bridge cycling
kinetics (Haworth et al., 2004; Cuello et al., 2007), suggesting a
beneficial effect of PKD activation on cardiac function. PKD also
alters gene expression leading to hypertrophy and influencing
cardiac remodeling processes (Vega et al., 2004; Harrison et al.,
2006).
With a molecular mass ranging from 3,000 to 3,700 kDa, titin
is the largest known protein and its function as amolecular spring
is important for the elasticity of striated muscle. Spanning the
half-sarcomere from the Z-disk to the M-band, titin is expressed
in various isoforms that confer different elastic properties to
the sarcomere. Two main isoform classes of titin are expressed
in the human heart: a shorter, stiffer N2B (3,000 kDa) isoform
and several longer, more compliant, N2BA isoforms (>3,200
kDa). These variants differ in their elastic I-band region due to
alternative splicing, whereas the Z-disk, A-band, and M-band
regions of titin are essentially constitutively expressed. The titin
spring region has a complex sequence comprising two types of
extensible segments: (1) regions composed of immunoglobulin-
like (Ig-) domains (proximal; middle; distal) arranged in tandem;
and (2) intrinsically disordered structures, including a unique
sequence of the cardiac specific “N2-B” element (“N2-Bus”) and
the “PEVK” segment rich in proline, glutamate, valine, and lysine.
The titin filaments in cardiomyocytes are considered to be a
main determinant of myocardial “passive” stiffness, along with
the collagen fibers of the extracellular matrix and additional
factors such as diastolic Ca2+ levels. We have previously
demonstrated that the stiffness of cardiac titin is highly variable
and depends on titin isoform switching and/or post-translational
modifications such as phosphorylation and oxidation (Linke and
Hamdani, 2014).
In our previous study, using a CaMKII knockout mouse
model together with the stable isotope labeling of amino
acids in cell culture (SILAC) mouse model, we found ∼20
CaMKII-dependent phosphosites along the titin molecule
(Hamdani et al., 2013b). Some phosphosites were located within
the extensible region of titin, e.g., at the N2-Bus and PEVK spring
elements, while others were within the A-band, M-band, and Z-
disk regions of titin. Using this approach, we also detected >50
additional titin phosphosites that appeared to be not regulated by
CaMKII. As regards to other kinases, protein kinase A and G and
ERK2 were shown to phosphorylate the titin springs at specific
sites within the cardiac-specific N2-Bus element (Kruger et al.,
2009; Kotter et al., 2013). This modification alters the molecular
stiffness of N2-Bus. Yet another kinase, PKCα, was shown to
phosphorylate titin’s PEVK element (Hidalgo et al., 2009).
A well-known substrate of PKD, among others, is heat
shock protein 27 (HSP27) (Doppler et al., 2005). HSPs are
molecular chaperones comprising a large family of proteins
involved in protection against various forms of cellular stress
(Mymrikov et al., 2011). HSPs generally facilitate protein
refolding, target misfolded proteins to the proteasome and
stabilize and transport partially folded proteins to different
cellular compartments. Under various environmental insults
such as heat, oxidative stress or acidosis, protein denaturation
occurs and leads to unfolding and undesirable protein aggregates
(Mymrikov et al., 2011). HSP27 is a small (ATP-independent)
HSP whose function is regulated, in part, by posttranslational
modifications, including phosphorylation at Ser-18, Ser-78, Ser-
82, and Thr-143 (Kostenko and Moens, 2009; Mymrikov et al.,
2011). Previous work showed that the unfolded Ig regions
of I-band titin, but not the intrinsically disordered segments,
can aggregate, causing high titin-dependent myocyte stiffness,
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FIGURE 1 | Volcano plots showing changes in the cardiac proteome and phosphoproteome in protein kinase D 1 (PKD1)-cKO and matched wild-type (WT) mouse
hearts. (A) Volcano plot of whole cardiac proteome with identified significantly up- or down-regulated peptides in wild type (WT) vs. cardiomyocyte specific Protein
Kinase D1 (PKD1) knock-out (KO) animals. (B) Volcano plot of whole cardiac phosphoproteome with identified significantly hyper- or hypo-phosphorylated peptides in
WT vs. PKD1 cKO mice.
(Continued)
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FIGURE 1 | (C) Volcano plot of myofilament and calcium handling proteins with significantly up- or down-regulated peptides in WT vs. PKD1 cKO mice. (D) Volcano
plot of myofilament and calcium handling proteins with significantly hyper- or hypo-phosphorylated peptides in WT vs. PKD1 cKO mice. (E) Volcano plot of kinases,
phosphatases, phosphodiesterases identified with significantly up- or down-regulated peptides in WT vs. PKD1 cKO mice. (F) Volcano plot of kinases, phosphatases,
phosphodiesterases identified with significantly hyper- or hypo-phosphorylated peptides in WT vs. PKD1 cKO mice. Protein content or phosphorylation considered as
significantly changed (-log10 p ≥ 1.3, log2 ratio ≥ ± 0.37) over the WT are color-coded. Only values with a—log10 p > 0 are shown. Experiments were performed in
triplicates.
and that HSP27 prevented this aggregation and suppressed the
stiffening (Kotter et al., 2014). We speculated that cardiomyocyte
elastic function could be protected under stress, at least in part,
by HSP27 being regulated via PKD-mediated phosphorylation.
The main aim of the present study was to investigate the
effects of PKD on titin phosphorylation in vivo and resulting
functional changes using cardiomyocyte specific Prkd1, which
encodes for PKD1, knockout mice, SILAC mouse hearts, and
human hypertrophic cardiomyopathy (HCM) heart tissues. We
identified various PKD1-dependent phosphosites within titin
using quantitative mass spectrometry (MS) and showed that
PKD1-mediated titin-phosphorylation reduces cardiomyocyte
Fpassive. Additionally, we found increased oxidative stress in
human HCM tissues along with increased HSP27 expression and
phosphorylation. HCM tissues also showed increased CaMKII-
dependent phosphorylation at the PEVK andN2Bus titin regions.
High cardiomyocyte stiffness was corrected by incubation with
HSP27 and PKD, probably through relief of titin aggregation.
Taken together, our results highlight the important roles of PKD
and HSP27, in the presence of oxidative stress, in modulating
diastolic function via titin-based stiffness regulation.
METHODS
Detailed methods descriptions are provided in the online
Supplementary Methods.
Human Heart Tissues
The investigation conforms to the principles outlined in the
Declaration of Helsinki and samples were obtained after
informed consent and with approval of the local Ethics
Committee. LV tissue was obtained from end-stage heart failure
patients (NYHA III or IV; n= 10), hypertrophic cardiomyopathy
(male, mean age 45 years). LV tissue from non-failing donor
hearts (N = 10; +- 40 years of age) served as reference and was
obtained from donor hearts (n= 5).
Cardiomyocyte Specific Prkd1 Knock-Out
Mice
All animal procedures were performed in accordance with
the guidelines of Charité Universitätsmedizin Berlin as well
as Max-Delbrück Center for Molecular Medicine and were
approved by the Landesamt für Gesundheit und Soziales
(LaGeSo, Berlin, Germany) for the use of laboratory animals
(permit number: G 0229/11) and followed the ‘Principles of
Laboratory Animal Care’ (NIH publication no. 86–23, revised
1985) as well as the current version of German Law on
the Protection of Animals. The generation and usage of
the conditional Prkd1 allele was published elsewhere (Fielitz
et al., 2008; Kim et al., 2008). The Cre-loxP recombination
system was used for the generation of a conditional Prkd1
allele. Prkd1loxP/loxP mice were crossed with Cre carrying
mice controlled by cardiomyocyte-specific alpha-myosin-heavy-
chain promotor (αMHC-Cre) (Agah et al., 1997) (cKO,
Prkd1loxP/loxP; αMHC-Cre). αMHC-Cre-negative littermates
were used as controls (WT, Prkd1loxP/loxP). Cardiac tissue was
obtained when mice were 8–10 weeks of age. N = 7 for both KO
and WT.
SILAC-Based Quantitative Mass
Spectrometry
We mixed equal amounts of protein lysates from heart
tissue (7.5mg) from the 13Lys6 heavy-labeled SILAC mouse
and a non-labeled WT or non-labeled Prkd1 cKO mouse.
After protein digestion and phosphopeptide enrichment, the
ratio of labeled:unlabeled peptides was determined by liquid
chromatography and tandem MS and used to identify the
cKO:WT ratio of titin phosphopeptides (Kruger et al., 2008).
Titin Isoform Separation
Homogenized myocardial samples were analyzed by 1.8% SDS-
PAGE. Protein bands were visualized by Coomassie staining and
analyzed densitometrically.
All-Titin Phosphorylation Assays
Titin bands were stained with anti-phospho-antibody directed
against phospho-serine/threonine. Phospho-protein signals were
indexed to total-protein signals and normalized to the intensity of
coomassie staining to correct for differences in sample loading.
Alternatively, all-titin phosphorylation was measured by PKD-
mediated back-phosphorylation (Hamdani et al., 2013b).
Titin and Phosphotitin Western Blots
Western blots were performed using custom-made, affinity-
purified, anti-phosphoserine-specific antibodies directed
against phospho-Ser-4010, -Ser-4062, -Ser-4099 (all N2Bus),
-Ser-11878, and –Ser-12022 (both PEVK), of human titin
(UniProtKB identifyer, Q8WZ42), and antibodies recognizing
the corresponding nonphosphorylated sequence at these sites
(Hamdani et al., 2013b). We also used phosphosite-specific
antibodies against phospho-Ser-3991, -Ser-4043, -Ser-4080 (all
N2Bus), -Ser-12742, and –Ser-12884 (both PEVK), of mouse
titin (UniProtKB identifyer, A2ASS6) (Hamdani et al., 2013b).
Force Measurements on Isolated
Cardiomyocytes
Cardiomyocytes were skinned and single isolated cells (n = 12–
42/5–6 heart/group) attached between a force transducer and
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FIGURE 2 | Titin phosphorylation and titin isoform composition in protein kinase D1 knockout (PKD1 cKO) and matched wild-type (WT) mouse hearts. (A) Volcano
plot of SILAC-quantified titin phosphosites in heart tissue of PKD1 cKO vs. WT mice (n = 3 hearts/group). (B) Titin isoform composition. (C) Site-specific
phosphorylation (P) of titin-N2B isoform at Ser3991 within N2Bus. (D) Site-specific P of titin-N2B isoform at Ser4043 within N2Bus. (E) Site-specific P of titin-N2B
isoform at Ser4080 within N2Bus. (F) Site-specific P of titin-N2B isoform at Ser12742 within PEVK segment. (G) Site-specific P of titin-N2B isoform at Ser12884
within PEVK segment. (H) Total N2B-titin phosphorylation in PKD1 cKO/WT hearts. Western blot data are means ± SEM; n = 7 hearts/group; each heart analyzed in
duplicate. *P < 0.05 in Students unpaired t-test.
motor (Hamdani et al., 2013a,b). Fpassive was recorded over the
sarcomere length (SL) range, 1.8–2.4µm, and was measured
before/after PKD and/or HSP27 incubation.
Quantification of Tissue Oxidative Stress
Myocardial levels (n = 7 LV sample/group) of oxidative stress
markers were tested with enzyme-linked immunosorbent assay
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TABLE 1 | Significantly changed titin phosphosites (–log 10 p-value KO/WT > 1.3).
Position
within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
S33880 A2ASS6 −0.659036 1.33033 3 1 1 Class 1 DLYYYRRRRRSLGDMSDEELLLPIDDYLAMK
S264 A2ASS6 0.419615 1.33152 2 2 1 Class 1 PHKTPPRIPPKPKSRSPTPPSIAAKAQLARQ
S315 A2ASS6 0.40279 1.45166 2 1 0.997856 Class 1 PSPVRSVSPAGRISTSPIRSVKSPLLIRKTQ
S16544 A2ASS6 −0.489219 1.48858 3 1 0.993809 Class 1 AEEEEPFSLPLTERLSINNSKQGESQLRIRD
S20332 A2ASS6 −0.239112 1.58029 2 1 1 Class 1 IIGYVVEMRPKIADASPDEGWKRCNAAAQLI
S264 A2ASS6 0.767076 2.14935 2 3 1 Class 1 PHKTPPRIPPKPKSRSPTPPSIAAKAQLARQ
T266 A2ASS6 0.767076 2.14935 2 3 1 Class 1 KTPPRIPPKPKSRSPTPPSIAAKAQLARQQS
S262 A2ASS6 0.720452 2.29218 2 3 1 Class 1 QLPHKTPPRIPPKPKSRSPTPPSIAAKAQLA
S322 A2ASS6 0.325277 3.06343 2 1 1 Class 1 SPAGRISTSPIRSVKSPLLIRKTQTTTMATG
S307 A2ASS6 0.509144 3.60898 2 2 1 Class 1 VRHVRAPTPSPVRSVSPAGRISTSPIRSVKS
Z-disk.
A-band.
M-band.
Multiplicity contains information about the phosphorylation of the peptides (single. double. triply phosphorylated).
TABLE 2 | Detected phosphosites in the elastic I band titin spring (–log 10 p-value KO/WT >0).
Position
within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
T9146 A2ASS6 −0.650309 0.429695 3 1 0.616703 Class 2 KERLIPPSFTKKLSETVEETEGNSFKLEGRV
S3286 A2ASS6 −0.938293 0.866542 2 1 0.851679 Class 1 RPQPKISWYKEEQLLSTGFKCKFLHDGQEYT
S3977 A2ASS6 −0.319098 0.36361 2 1 0.840288 Class 1 CTEGKILMASADTLKSTGQDVALRTEEGKSL
T13665 A2ASS6 −0.316873 0.41921 2 1 1 Class 1 CEVSREPKTFRWLKGTQEITGDDRFELIKDG
S13228 A2ASS6 −0.273069 0 2 1 0.993076 Class 1 DIPGEWKLKGELLRPSPTCEIKAEGGKRFLT
S9201 A2ASS6 −0.230981 0 2 1 1 Class 1 IMFKNNALLLQVKRASMADAGLYTCKATNDA
S9144 A2ASS6 −0.203903 0.163212 2 1 1 Class 1 NIKERLIPPSFTKKLSETVEETEGNSFKLEG
S4175 A2ASS6 −0.168399 0.396358 3 1 1 Class 1 HEEDKIDVQGGRDHLSDAQKVETVIEAEADS
T14268 A2ASS6 −0.16409 0.087451 2 1 0.99985 Class 1 VFTKNLANLEVSEGDTIKLVCEVSKPGAEVI
S9459 A2ASS6 −0.158813 0.124587 3 1 1 Class 1 DLRAMLKKTPALKKGSGEEEEIDIMELLKNV
S13204 A2ASS6 −0.0662166 0.089154 2 1 0.880947 Class 1 LKPIEDVTIYEKESASFDAEISEEDIPGEWK
S4018 A2ASS6 −0.018641 0 2 1 0.675564 Class 2 VLLKEEQSEVVAVPTSQTSKSEKEPEAIKGV
S3991 A2ASS6 −0.0149712 0.0107483 2 1 0.999502 Class 1 KSTGQDVALRTEEGKSLSFPLALEEKQVLLK
S3870 A2ASS6 −0.00516502 0.0056415 3 1 0.991661 Class 1 EPEGVFPGASSAAQVSPVTIKPLITLTAEPK
S14664 A2ASS6 0.0113125 0.0110327 2 1 1 Class 1 REIKEGKKYKFEKDGSIHRLIIKDCRLEDEC
S13764 A2ASS6 0.200173 0 2 1 1 Class 1 SWFKNDQRLHTSKRVSMHDEGKTHSITFKDL
S3676 A2ASS6 0.258327 0 4 1 0.878152 Class 1 EDMPLYTSVCYTIIHSPDGSGTFIVNDPQRG
S12678 A2ASS6 0.331543 0.65471 3 1 1 Class 1 IEKPKLKPRPPARPPSPPKEDVKEKMFQLKA
T10276 A2ASS6 0.395205 0 3 1 0.637793 Class 2 EVQKKVVTEEKIAIITQREESPPPAVPEIPK
S10281 A2ASS6 0.719508 0.777963 3 1 0.999995 Class 1 VVTEEKIAIITQREESPPPAVPEIPKKKVPE
S12871 A2ASS6 0.829341 1.09019 3 1 1 Class 1 AKPKGPIKGVAKKTPSPIEAERKKLRPGSGG
S12884 A2ASS6 0.94305 0.52056 3 1 1 Class 1 TPSPIEAERKKLRPGSGGEKPPDEAPFTYQL
S12871 A2ASS6 0.981417 0.3495 3 2 1 Class 1 AKPKGPIKGVAKKTPSPIEAERKKLRPGSGG
T12869 A2ASS6 0.981417 0.3495 3 2 1 Class 1 EAAKPKGPIKGVAKKTPSPIEAERKKLRPGS
Proximal Ig region.
N2B-element.
Middle Ig region.
PEVK.
Distal Ig domains.
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TABLE 3 | Downregulated titin phosphosites (log2 ratio KO/WT <−0.37).
Position
within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
S23560 A2ASS6 −0.372779 0 3 1 0.692852 Class 2 PGPPGNPRVLDTSRSSISIAWNKPIYDGGSE
S18225 A2ASS6 −0.376743 0.548646 2 1 0.5 Class 2 PPGPPFPKVTDWTKSSVDLEWSPPLKDGGSK
S30484 A2ASS6 −0.380153 0 2 1 0.999969 Class 1 TWKLEEMRLKETDRMSIATTKDRTTLTVKDS
S34451 A2ASS6 −0.384564 0.573934 2 1 0.999956 Class 1 TLTVQKARVIEKAVTSPPRVKSPEPRVKSPE
S33933 A2ASS6 −0.390718 0.578927 2 1 0.999999 Class 1 SRSPPRFELSSLRYSSPPAHVKVEDRRRDFR
S34808 A2ASS6 −0.390976 0.349281 2 1 1 Class 1 IAEEVKRSAAASLEKSIVHEEVTKTSQASEE
S26062 A2ASS6 −0.391391 0 3 1 0.992938 Class 1 KWSVVAESKVCNAVVSGLSSGQEYQFRVKAY
S21726 A2ASS6 −0.391912 0.585051 2 1 0.999998 Class 1 FLTEENKWQRVMKSLSLQYSTKDLKEGKEYT
T27227 A2ASS6 −0.392365 0 3 1 0.598045 Class 2 QATVAWKKDGQVLRETTRVNVASSKTVTTLS
S34476 A2ASS6 −0.399261 0.538309 2 1 1 Class 1 RVKSPETVKSPKRVKSPEPVTSHPKAVSPTE
S28859 A2ASS6 −0.403171 0.471662 2 1 0.990318 Class 1 EPVVAKNAFVTPGPPSIPEVTKITKNSMTVV
T4070 A2ASS6-3 −0.408659 0.331878 3 1 0.998519 Class 1 RELLSFPVEIQITAATPTPEQNKECRELFEL
S22271 A2ASS6 −0.42308 0 3 1 0.944504 Class 1 VSVLDVPGPPGPIEISNVSAEKATLTWTPPL
S1196 A2ASS6 −0.429651 0.300969 3 1 0.887311 Class 1 ALVKTQQEMLYQTQMSTFIQEPKVGEIAPGF
S29764 A2ASS6 −0.433024 0.621301 2 1 0.999999 Class 1 FGPEYFDGLVIKSGDSLRIKALVQGRPVPRV
S26804 A2ASS6 −0.433475 0 3 1 0.524536 Class 2 LYPPGPPSNPKVTDTSRSSVSLAWNKPIYDG
S22184 A2ASS6 −0.435231 0 2 1 0.999983 Class 1 LDPTIKDGLTVKAGDSIVLSAISILGKPLPK
S28389 A2ASS6 −0.440064 0 2 1 0.999873 Class 1 ESVTLKWEPPKYDGGSHVTNYIVLKRETSTA
S19152 A2ASS6 −0.442809 0 2 1 0.686958 Class 2 RKDVATAQWSPLSTTSKKKSHMAKHLTEGNQ
S34292 A2ASS6 −0.458658 1.00349 2 1 0.997471 Class 1 LTKTEAYAVSSFKRTSELEAASSVREVKSQM
S848 A2ASS6 −0.472572 0.731925 2 1 0.999987 Class 1 ASIAGSAIATLQKELSATSSTQKITKSVKAP
S19518 A2ASS6 −0.479462 0 3 1 0.999999 Class 1 DITENAATVSWTLPKSDGGSPITGYYVERRE
T4827 A2ASS6-3 −0.480703 0 3 2 0.682593 Class 2 VRDTKHKAQLVQSDSTTSMEVEEVTFNTVYE
S16544 A2ASS6 −0.489219 1.48858 3 1 0.993809 Class 1 AEEEEPFSLPLTERLSINNSKQGESQLRIRD
S29489 A2ASS6 −0.490109 0.49045 2 1 0.999929 Class 1 GGGEITCYSIEKREASQTNWKMVCSSVARTT
S35097 A2ASS6 −0.491363 0.979128 3 1 0.972789 Class 1 ESFVEMSSSSFMGKSSMTQLESSTSRMLKAG
S29997 A2ASS6 −0.496859 0.246525 3 1 0.999978 Class 1 KKSTRWVKVISKRPISETRFKVTGLVEGNEY
S23358 A2ASS6 −0.498498 0.499119 3 1 0.855607 Class 1 RPGPPEGPLAVSDVTSEKCVLSWLPPLDDGG
S262 A2ASS6 −0.501588 0 2 1 1 Class 1 QLPHKTPPRIPPKPKSRSPTPPSIAAKAQLA
S30452 A2ASS6 −0.513035 0.782215 2 1 0.968235 Class 1 DLTGITNQLITCKAGSTFTIDVPISGRPAPK
S16548 A2ASS6 −0.515562 0.899345 3 1 0.999832 Class 1 EPFSLPLTERLSINNSKQGESQLRIRDSLRP
S24061 A2ASS6 −0.515855 0.613502 2 1 0.97456 Class 1 SVTLSWEPPKYDGGSSINNYIVEKRDTSTTA
T23053 A2ASS6 −0.515985 0.758139 2 1 0.999999 Class 1 SVVANYPFKVPGPPGTPQVTAVTKDSMTISW
S1120 A2ASS6 −0.516292 0.722335 2 1 1 Class 1 CQIGGNPKPHVYWKKSGVPLTTGYRYKVSYN
S21895 A2ASS6 −0.522994 0.473161 2 1 1 Class 1 EAMTLKWGPPKDDGGSEITNYVLEKRDSVNN
S34756 A2ASS6 −0.525721 0.586585 2 1 1 Class 1 VSTQKTSEVTSQKKASAQEEISQKALTSEEI
S21162 A2ASS6 −0.54349 0.319895 2 1 0.836052 Class 1 VNRKDSGDYTITAENSSGSKSATIKLKVLDK
S34778 A2ASS6 −0.543969 0.489795 2 1 0.999964 Class 1 QKALTSEEIKMSEVKSHETLAIKEEASKVLI
T22513 A2ASS6 −0.551522 0 3 1 0.958776 Class 1 VEHQKVGDDAWIKDTTGTALRITQFVVPDLQ
T24135 A2ASS6 −0.561529 0.975063 2 1 1 Class 1 PVVAQYPFKVPGPPGTPFVTLASKDSMEVQW
T23980 A2ASS6 −0.573932 0.604136 3 1 0.631224 Class 2 PPAVTWHKDDIPLKQTTRVNAESTENNSLLT
S21730 A2ASS6 −0.574432 0.464884 2 1 0.798102 Class 1 ENKWQRVMKSLSLQYSTKDLKEGKEYTFRVS
S23609 A2ASS6 −0.587423 0 2 1 0.995346 Class 1 VTPPAGLKATSYTITSLIENQEYKIRIYAMN
S4650 A2ASS6-3 −0.606701 0 3 1 0.981316 Class 1 ALFQTPSADVEEANVSETGASVENGDKTFIS
T25062 A2ASS6 −0.625343 0 3 1 0.499999 Class 2 KPSISWTKDGMPLKQTTRINVTDSLDLTTLS
T25063 A2ASS6 −0.625343 0 3 1 0.499999 Class 2 PSISWTKDGMPLKQTTRINVTDSLDLTTLSI
S16620 A2ASS6 −0.62959 0.594816 3 1 0.999999 Class 1 DSVLCKWEPPLDDGGSEIINYTLEKKDKTKP
S25817 A2ASS6 −0.632049 0.301091 2 1 1 Class 1 VKPEDKLEAPELDLDSELRKGIVVRAGGSAR
S34207 A2ASS6 −0.63678 0 2 1 0.992242 Class 1 AEVKWYHNGVELQESSKIHYTNTSGVLTLEI
S20215 A2ASS6 −0.644393 0.578427 2 1 0.989323 Class 1 EMTVVWNAPEYDGGKSITGYYLEKKEKHAVR
(Continued)
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Position
within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
T30560 A2ASS6 −0.645399 0.70904 2 1 1 Class 1 ESCVLSWTEPKDDGGTEITNYIVEKRESGTT
T9146 A2ASS6 −0.650309 0.429695 3 1 0.616703 Class 2 KERLIPPSFTKKLSETVEETEGNSFKLEGRV
S33880 A2ASS6 −0.659036 1.33033 3 1 1 Class 1 DLYYYRRRRRSLGDMSDEELLLPIDDYLAMK
S21163 A2ASS6 −0.662774 0 2 1 0.555375 Class 2 NRKDSGDYTITAENSSGSKSATIKLKVLDKP
S32940 A2ASS6 −0.669661 0.567747 3 1 0.991067 Class 1 DSVNLTWTEPASDGGSKVTNYIVEKCATTAE
T27381 A2ASS6 −0.676248 0.40741 2 1 0.987482 Class 1 AVVAEYPFSPPGPPGTPKVVHATKSTMVVSW
S22466 A2ASS6 −0.68697 0.37929 3 1 0.971535 Class 1 NPVLMKDVAYPPGPPSNAHVTDTTKKSASLA
S15406 A2ASS6 −0.717398 0.426932 2 1 1 Class 1 NSIFLTWDPPKNDGGSRIKGYIVEKCPRGSD
S24060 A2ASS6 −0.726107 0.454637 2 1 0.965865 Class 1 DSVTLSWEPPKYDGGSSINNYIVEKRDTSTT
S17508 A2ASS6 −0.743691 0.827831 3 1 0.854636 Class 1 PPGPPSCPEVKDKTKSSISLAWKPPAKDGGS
S22646 A2ASS6 −0.746741 0 3 1 0.999997 Class 1 TGKFVMTIENPAGKKSGFVNVRVLDTPGPVL
Y21461 A2ASS6 −0.750766 0 2 1 0.997236 Class 1 NTEYQFRVYAVNKIGYSDPSDVPDKHCPKDI
S34464 A2ASS6 −0.758656 0.611225 2 1 1 Class 1 VTSPPRVKSPEPRVKSPETVKSPKRVKSPEP
S19128 A2ASS6 −0.761375 0.661405 3 1 1 Class 1 DSCYLTWKEPLDDGGSVVTNYVVERKDVATA
S17509 A2ASS6 −0.765849 0.574468 2 1 0.499998 Class 2 PGPPSCPEVKDKTKSSISLAWKPPAKDGGSP
S34009 A2ASS6 −0.77042 0.791858 2 1 1 Class 1 LLRPVTTTQRLSEYKSELDYMSKEEKSKKKS
S30820 A2ASS6 −0.787034 0 3 1 0.779125 Class 1 VLAKNAAGVISKGSESTGPVTCRDEYAPPKA
S34653 A2ASS6 −0.82199 0.752192 2 1 0.95726 Class 1 SSKPVIVTGLRDTTVSSDSVAKFTIKVTGEP
S32936 A2ASS6 −0.824822 0 3 1 0.909829 Class 1 DVSRDSVNLTWTEPASDGGSKVTNYIVEKCA
T16910 A2ASS6 −0.831267 0.77835 3 1 1 Class 1 LDVSVKGGIQIMAGKTLRIPAEVTGRPVPTK
S15236 A2ASS6 −0.836399 0.546251 3 1 0.997816 Class 1 DQVLEEGDRVKMKTISAYAELVISPSERTDK
S21637 A2ASS6 −0.851016 0.751694 2 1 0.999673 Class 1 WSTVTTECSKTSFRVSNLEEGKSYFFRVFAE
T30103 A2ASS6 −0.851493 0 3 1 0.499919 Class 2 DWHKVNTEPCVKTRYTVTDLQAGEEYKFRVS
S32230 A2ASS6 −0.864269 0.82444 2 1 0.991873 Class 1 DPFDKPSQPGELEILSISKDSVTLQWEKPEC
S34005 A2ASS6 −0.876525 0 3 1 0.999798 Class 1 EEEELLRPVTTTQRLSEYKSELDYMSKEEKS
S18731 A2ASS6 −0.87685 0.25695 3 1 0.995523 Class 1 EYMVISWKPPLDDGGSEITNYIIEKKELGKD
S4248 A2ASS6-3 −0.893375 0 4 1 0.967119 Class 1 VQGEPVRTHFYDHTVSPFAAQSNIKEYTIRE
T30453 A2ASS6 −0.895531 0.674399 3 1 0.861201 Class 1 LTGITNQLITCKAGSTFTIDVPISGRPAPKV
S1805 A2ASS6 −0.895653 0.717555 2 1 1 Class 1 GTDHTSATLIVKDEKSLVEESQLPDGKKGLQ
S15266 A2ASS6 −0.907094 0 2 1 0.977731 Class 1 KGIYTLTLENPVKSISGEINVNVIAPPSAPK
S25399 A2ASS6 −0.923229 0.531448 2 1 0.967678 Class 1 VIAKNAAGAISKPSDSTGPITAKDEVELPRI
S27960 A2ASS6 −0.925189 0.489628 2 1 0.834475 Class 1 RVRSLNKMGASDPSDSSDPQVAKEREEEPVF
S3286 A2ASS6 −0.938293 0.866542 2 1 0.851679 Class 1 RPQPKISWYKEEQLLSTGFKCKFLHDGQEYT
T22529 A2ASS6 −0.943427 0.67514 2 1 1 Class 1 GTALRITQFVVPDLQTKEKYNFRISAINDAG
S4720 A2ASS6-3 −0.959846 0 3 1 0.9499 Class 1 PRGAVHGAEVPHRRLSLSQDLPFLMTGEQQD
S35060 A2ASS6 −0.967557 0 2 1 0.845469 Class 1 SASKQEASFSSFSSSSASSMTEMKFASMSAQ
Y20757 A2ASS6 −0.96841 0.688841 2 1 0.999745 Class 1 SSVLIIKDVTRKDSGYYSLTAENSSGSDTQK
S25797 A2ASS6 −0.975471 0.492227 2 1 0.999986 Class 1 IRVCALNKVGLGEAASVPGTVKPEDKLEAPE
S23925 A2ASS6 −1.00025 0.887458 3 1 0.999906 Class 1 VSAQNEKGISDPRQLSVPVIAKDLVIPPAFK
S25613 A2ASS6 −1.02282 0.946511 2 1 1 Class 1 PVLMKNPFVLPGPPKSLEVTNIAKDSMTVCW
S29299 A2ASS6 −1.03903 0.614927 2 1 0.999999 Class 1 TDYLVERKGKGEQAWSHAGISKTCEIEIGQL
Y20182 A2ASS6 −1.04142 0.707871 3 1 1 Class 1 TGPPTESKPVIAKTKYDRPGRPDPPEVTKVS
S35104 A2ASS6 −1.0585 0 2 1 0.746582 Class 2 SSSFMGKSSMTQLESSTSRMLKAGGRGIPPK
S15616 A2ASS6 −1.06363 0.707178 2 1 0.999998 Class 1 GSKITNYVVERKATDSDVWHKLSSTVKDTNF
S20732 A2ASS6 −1.08258 0.581344 2 1 0.997277 Class 1 PICKWKKGDDEVVTSSHLAIHKADGSSVLII
T16946 A2ASS6 −1.0848 0 2 1 1 Class 1 EGELDKERVIIENVGTKSELIIKNALRKDHG
S24436 A2ASS6 −1.0957 0.769352 3 1 0.997797 Class 1 KVLDRPGPPEGPVAISGVTAEKCTLAWKPPL
S19776 A2ASS6 −1.13133 0 4 1 0.570984 Class 2 VRADHGKYIISAKNSSGHAQGSAIVNVLDRP
T30100 A2ASS6 −1.14081 0.86237 2 1 0.999845 Class 1 DLGDWHKVNTEPCVKTRYTVTDLQAGEEYKF
(Continued)
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S28970 A2ASS6 −1.14229 0.390143 2 1 0.848484 Class 1 PPGPPAKIRIADSTKSSITLGWSKPVYDGGS
S23728 A2ASS6 −1.15678 0 2 1 0.680757 Class 2 FDSGKYILTVENSSGSKSAFVNVRVLDTPGP
S23604 A2ASS6 −1.18392 0 2 1 0.760984 Class 1 DEWQVVTPPAGLKATSYTITSLIENQEYKIR
T22805 A2ASS6 −1.18392 0.725798 2 1 0.948992 Class 1 IEAQRKGSDQWTHISTVKGLECVVRNLTEGE
S25730 A2ASS6 −1.2141 1.02176 2 1 0.999999 Class 1 AHVVDTTKNSITLAWSKPIYDGGSEILGYVV
S24155 A2ASS6 −1.21435 0.495954 3 1 0.938049 Class 1 LASKDSMEVQWHEPVSDGGSKVIGYHLERKE
T23603 A2ASS6 −1.22489 0.565233 2 1 0.891141 Class 1 EDEWQVVTPPAGLKATSYTITSLIENQEYKI
S29402 A2ASS6 −1.22605 1.20053 2 1 1 Class 1 LKDGLPLKESEYVRFSKTENKITLSIKNSKK
T25518 A2ASS6 −1.23095 0.735191 3 1 0.981598 Class 1 KVLDRPGPPEGPVQVTGVTAEKCTLAWSPPL
T19879 A2ASS6 −1.23865 1.098 3 1 1 Class 1 CAENKVGVGPTIETKTPILAINPIDRPGEPE
Y29398 A2ASS6 −1.26528 0.758789 2 1 1 Class 1 SISWLKDGLPLKESEYVRFSKTENKITLSIK
S32140 A2ASS6 −1.27419 0.799964 2 1 0.998818 Class 1 PEVLDVTKSSVSLSWSRPKDDGGSRVTGYYI
S28985 A2ASS6 −1.28346 0 2 1 0.999999 Class 1 SSITLGWSKPVYDGGSDVTGYVVEMKQGDEE
S35029 A2ASS6 −1.33441 0 3 1 0.960754 Class 1 PLVEEPPREVVLKTSSDVSLHGSVSSQSVQM
S34457 A2ASS6 −1.40297 0 2 2 1 Class 1 ARVIEKAVTSPPRVKSPEPRVKSPETVKSPK
S35096 A2ASS6 −1.44254 0.872837 2 1 0.869587 Class 1 QESFVEMSSSSFMGKSSMTQLESSTSRMLKA
T22515 A2ASS6 −1.45339 0 3 1 0.998937 Class 1 HQKVGDDAWIKDTTGTALRITQFVVPDLQTK
S25026 A2ASS6 −1.48484 0.743171 3 1 0.949735 Class 1 IAKDLVIEPDVRPAFSSYSVQVGQDLKIEVP
S21724 A2ASS6 −1.49957 0 2 1 0.965611 Class 1 VDFLTEENKWQRVMKSLSLQYSTKDLKEGKE
S27185 A2ASS6 −1.55785 0.714422 2 1 1 Class 1 QLGVPVIAKDIEIKPSVELPFNTFNVKANDQ
S34009 A2ASS6 −2.60171 0 2 2 1 Class 1 LLRPVTTTQRLSEYKSELDYMSKEEKSKKKS
Novex-3 (A2ASS6-3).
Z-disk.
Proximal Ig region.
Middle Ig region.
A-band.
M-band.
(ELISA). Hydrogen peroxide (H2O2) was assessed in LV tissue
homogenates (n = 4–10/group). Samples containing equal
amounts of total protein were analyzed for H2O2 formation.
Total reduced glutathione in heart samples was determined in
duplicate with a colorimetric glutathione assay kit (CS0260,
Sigma Aldrich).
Amount and Phosphorylation of PKD and
HSP27
The content of PKD and HSP27, as well as their phosphorylation
were measured by 15% SDS–PAGE and western blot.
CaMKII Content and Activity
The content of CaMKII was determined using 15% SDS–PAGE
and western blot and its activity by using non-radioactive kinase
activity-assay kit (CycLex).
Immunofluorescence Imaging
Frozen histological LV sections (n = 3/group) were fixed,
blocked and dual-stained with anti-PKD (Sigma-Aldrich;
dilution 1:200) or anti-phospho-HSP27 (Ser 82) (Cell Signaling
Technology; 1:50) and anti-α-actinin (sarcomere; Sigma-
Aldrich; dilution 1:400) antibody, and were incubated with
the appropriate secondary antibodies: (FITC) anti-mouse
(Rockland Immunochemicals Inc, Limerick, PA, USA;
dilution 1:300) and Cy3 anti-rabbit (Jackson ImmunoResearch
Laboratories Inc, West Grove, PA, USA; dilution 1:100).
Immunostained samples were analyzed by confocal laser
scanning microscopy (Nikon Eclipse Ti-E Inverted Microscope
System; Nikon Instruments, Nikon Corp, Shinagawa, Tokyo,
Japan). Immunofluorescence imaging was processed equally
among groups, for 2D intensity histogram analysis the Coloc2
plugin in FIJI was used.
Electron Microscopy (EM)
Frozen LV samples were cut, fixed and blocked. Samples
were then immunolabeled against primary antibodies of PKD
(Abcam; 1:200) and HSP27 (Abcam; 1:200), then with nanogold
conjugated secondary antibodies. After counterstaining with
osmium-tetroxide, and dehydration, blocks were embedded into
resin. 50 nm thin sections were cut.
Statistics
Values are given as mean ± SEM. Statistically significant
differences were tested using Bonferroni adjusted unpaired or
paired Student’s t-test, with P < 0.05 considered significant.
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TABLE 4 | Upregulated titin phosphosites (log2 ratio KO/WT > 0.37).
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within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
T314 A2ASS6 0.386936 1.09573 2 1 0.982868 Class 1 TPSPVRSVSPAGRISTSPIRSVKSPLLIRKT
T10276 A2ASS6 0.395205 0 3 1 0.637793 Class 2 EVQKKVVTEEKIAIITQREESPPPAVPEIPK
S315 A2ASS6 0.40279 1.45166 2 1 0.997856 Class 1 PSPVRSVSPAGRISTSPIRSVKSPLLIRKTQ
S264 A2ASS6 0.419615 1.33152 2 2 1 Class 1 PHKTPPRIPPKPKSRSPTPPSIAAKAQLARQ
S35038 A2ASS6 0.429709 0.499475 2 1 0.987556 Class 1 VVLKTSSDVSLHGSVSSQSVQMSASKQEASF
S262 A2ASS6 0.433659 0.711028 2 2 1 Class 1 QLPHKTPPRIPPKPKSRSPTPPSIAAKAQLA
S23788 A2ASS6 0.438542 0 2 1 0.993369 Class 1 KNYIVEKRESTRKAYSTVATNCHKTSWKVDQ
S1527 A2ASS6 0.44247 0 3 1 0.86319 Class 1 VIKEDGTQSLIIVPASPSDSGEWTVVAQNRA
S31025 A2ASS6 0.474799 0 3 1 0.838063 Class 1 GLGVPVESEPIVARNSFTIPSQPGIPEEVGA
S834 A2ASS6 0.503759 0.543576 2 1 0.99992 Class 1 VSKISVPKTEHGYEASIAGSAIATLQKELSA
S307 A2ASS6 0.509144 3.60898 2 2 1 Class 1 VRHVRAPTPSPVRSVSPAGRISTSPIRSVKS
T314 A2ASS6 0.608677 0 2 2 0.982868 Class 1 TPSPVRSVSPAGRISTSPIRSVKSPLLIRKT
S774 A2ASS6 0.620881 0.40983 2 1 0.98142 Class 1 HVVPQAVKPAVIQAPSETHIKTTDQMGMHIS
S879 A2ASS6 0.704194 0 3 2 0.998042 Class 1 TVKPGETRVRAEPTPSPQFPFADMPPPDTYK
S10281 A2ASS6 0.719508 0.777963 3 1 0.999995 Class 1 VVTEEKIAIITQREESPPPAVPEIPKKKVPE
S262 A2ASS6 0.720452 2.29218 2 3 1 Class 1 QLPHKTPPRIPPKPKSRSPTPPSIAAKAQLA
S264 A2ASS6 0.767076 2.14935 2 3 1 Class 1 PHKTPPRIPPKPKSRSPTPPSIAAKAQLARQ
T266 A2ASS6 0.767076 2.14935 2 3 1 Class 1 KTPPRIPPKPKSRSPTPPSIAAKAQLARQQS
S799 A2ASS6 0.787488 0 3 1 0.834492 Class 1 MGMHISSQVKKTTDISTERLVHVDKRPRTAS
S12871 A2ASS6 0.829341 1.09019 3 1 1 Class 1 AKPKGPIKGVAKKTPSPIEAERKKLRPGSGG
S12884 A2ASS6 0.94305 0.52056 3 1 1 Class 1 TPSPIEAERKKLRPGSGGEKPPDEAPFTYQL
S12871 A2ASS6 0.981417 0.3495 3 2 1 Class 1 AKPKGPIKGVAKKTPSPIEAERKKLRPGSGG
T12869 A2ASS6 0.981417 0.3495 3 2 1 Class 1 EAAKPKGPIKGVAKKTPSPIEAERKKLRPGS
S838 A2ASS6 1.20302 0 3 1 0.999952 Class 1 SVPKTEHGYEASIAGSAIATLQKELSATSST
S32133 A2ASS6 1.4809 0.355789 2 1 0.791719 Class 1 PEPPSNPPEVLDVTKSSVSLSWSRPKDDGGS
Z-disk.
PEVK.
A-band.
M-band.
RESULTS
We hypothesized that Prkd1 cKO mouse hearts would show
altered titin phosphorylation compared to matched WT hearts.
Quantitative Mass Spectrometry Detects
Disturbed Regulation in Prkd1 cKO Mice
Using the SILAC technique, we detected a wide range of
cardiac proteins that were either significantly upregulated
(>80 proteins), downregulated (>105 proteins) or unchanged
(remainder) in cKOs (Figure 1A). In total we detected 9,833
phosphosites (4,859 of them with −log10 p > 0) from 3,652
different proteins (2,507 of them with log10 p > 0) (Figure 1B).
In total, 505 proteins were downregulated in cKO (log2 ratio
KO/WT <−0.37) with a significant downregulation of 105
proteins. In addition to 422 proteins found to be upregulated
(log2 ratio KO/WT >0.37), 80 proteins showed a significant
upregulation, while the rest remained either unchanged or with
no relevant pvalue (Figure 1A). Among the significantly up-
or downregulated proteins were numerous myofilament
and calcium handling proteins, in addition to several
phosphatases and kinases (Figures 1C–F). We also detected
many cardiac peptides that were either hypophosphorylated (70
phosphopeptides), hyperphosphorylated (63 phosphopeptides),
or unchanged in cKOs (Figure 1B).
Quantitative Mass Spectrometry Detects
Conserved PKD Phosphosites in Titin
QuantitativeMSwas combined with amodified SILAC technique
to facilitate identification of PKD-dependent phosphorylation
sites in titin. Titin was among the proteins that showed the
largest alterations in phosphorylation in cKO compared to
WT hearts. We identified 332 titin phosphopeptide (including
77.7% serines, 19.3% threonines, and 3.0% tyrosines), including
258 phosphosites with a ratio of cKO to WT phosphorylation
levels (ratio WT/cKO) for titin. Among them, 164 phosphosites
were with –log10 p > 0 (Figure 2A). Most of the identified
phosphopeptides were class 1 (localization probability 0.75–
1.00), although 27 phosphopeptides showed a localization
probability <0.75 and were therefore class 2 phosphopeptides
(see Tables 1–5). The majority of the phosphopeptides showed
single phosphorylation, although some showed double
phosphorylation. According to the conservative estimate
that a cKO/WT ratio should be ≤ −0.37 or ≥ +0.37 in order to
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TABLE 5 | Unchanged titin phosphosites (−0.37 < log2 ratio KO/WT < 0.37).
Position
within titin
UniProt
identifyer
Log2 ratio
(KO/WT)
–Log 10
p-value KO/WT
Charge Multiplicity Localization
probability
Classification
of phosphosite
Sequence window
T26299 A2ASS6 −0.367305 0.338896 2 1 0.999988 Class 1 PVVVQYPFKEPGPPGTPFVTSISKDQMLVQW
S23354 A2ASS6 −0.359797 0 3 1 0.990613 Class 1 KVLDRPGPPEGPLAVSDVTSEKCVLSWLPPL
S34298 A2ASS6 −0.356955 0 3 1 0.609727 Class 2 YAVSSFKRTSELEAASSVREVKSQMTETRES
S34470 A2ASS6 −0.355278 0 2 1 1 Class 1 VKSPEPRVKSPETVKSPKRVKSPEPVTSHPK
S33875 A2ASS6 −0.353589 0.477593 3 2 1 Class 1 PSPDYDLYYYRRRRRSLGDMSDEELLLPIDD
S33880 A2ASS6 −0.353589 0.477593 3 2 1 Class 1 DLYYYRRRRRSLGDMSDEELLLPIDDYLAMK
S18562 A2ASS6 −0.350673 0.345871 2 1 1 Class 1 IGTEKFHKVTNDNLLSRKYTVKGLKEGDTYE
T22520 A2ASS6 −0.329784 0 3 1 0.995336 Class 1 DDAWIKDTTGTALRITQFVVPDLQTKEKYNF
S3977 A2ASS6 −0.319098 0.36361 2 1 0.840288 Class 1 CTEGKILMASADTLKSTGQDVALRTEEGKSL
S19146 A2ASS6 −0.318534 0.168528 2 1 0.995484 Class 1 TNYVVERKDVATAQWSPLSTTSKKKSHMAKH
T13665 A2ASS6 −0.316873 0.41921 2 1 1 Class 1 CEVSREPKTFRWLKGTQEITGDDRFELIKDG
S17098 A2ASS6 −0.305806 0.472482 2 1 0.933227 Class 1 PPTSPERLTYTERTKSTITLDWKEPRSDGGS
S24868 A2ASS6 −0.302999 0 2 1 0.998408 Class 1 KIKNYIVEKREATRKSYAAVVTNCHKNSWKI
S34470 A2ASS6 −0.302672 0.238728 2 2 1 Class 1 VKSPEPRVKSPETVKSPKRVKSPEPVTSHPK
S26806 A2ASS6 −0.301597 0 2 1 0.655766 Class 2 PPGPPSNPKVTDTSRSSVSLAWNKPIYDGGA
S18224 A2ASS6 −0.300622 0.391952 2 1 0.832005 Class 1 APPGPPFPKVTDWTKSSVDLEWSPPLKDGGS
S34464 A2ASS6 −0.2992 0.235518 2 2 1 Class 1 VTSPPRVKSPEPRVKSPETVKSPKRVKSPEP
S2080 A2ASS6 −0.298846 0.520376 2 1 1 Class 1 ITIPTFKPERIELSPSMEAPKIFERIQSQTV
S19448 A2ASS6 −0.273899 0 2 1 0.805061 Class 1 QDTRKGTWGVVSAGSSKLKLKVPHLQKGCEY
S13228 A2ASS6 −0.273069 0 2 1 0.993076 Class 1 DIPGEWKLKGELLRPSPTCEIKAEGGKRFLT
S27374 A2ASS6 −0.266139 0 3 1 0.820467 Class 1 SSYSESSAVVAEYPFSPPGPPGTPKVVHATK
S20517 A2ASS6 −0.265893 0 3 1 0.748614 Class 2 TSCHVSWAPPENDGGSQVTHYIVEKREAERK
S28343 A2ASS6 −0.263658 0 3 1 0.780076 Class 1 SVTTDAGRYEITAANSSGTTKTFINIIVLDR
S32318 A2ASS6 −0.262435 0.516907 2 1 0.999971 Class 1 SRPRRTAMSVKTKLTSGEAPGVRKEMADVTT
S3622 A2ASS6-3 −0.260512 0 3 1 0.962608 Class 1 VEEKGMVRTIHFRSASPVRRADYVYNDEWSE
Y21274 A2ASS6 −0.257528 0 3 1 1 Class 1 VGDPILTEPAIAKNPYDPPGRCDPPVISNIT
T22220 A2ASS6 −0.252516 0.8886 3 1 0.940036 Class 1 AGKDIRPSDIAQITSTPTSSMLTVKYATRKD
S22152 A2ASS6 −0.241103 0 2 1 0.761358 Class 1 IRAKNTAGAISAPSESTGTIICKDEYEAPTI
S20332 A2ASS6 −0.239112 1.58029 2 1 1 Class 1 IIGYVVEMRPKIADASPDEGWKRCNAAAQLI
S9201 A2ASS6 −0.230981 0 2 1 1 Class 1 IMFKNNALLLQVKRASMADAGLYTCKATNDA
S4098 A2ASS6-3 −0.229673 0 3 1 1 Class 1 FELEPEVTPRDQAIQSPKHKFIFSSDITNEP
S27782 A2ASS6 −0.229019 0 3 1 0.547507 Class 2 DPFTTPSPPTSLEITSVTKDSMTLCWSRPET
T27228 A2ASS6 −0.228542 0.209869 3 1 0.955571 Class 1 ATVAWKKDGQVLRETTRVNVASSKTVTTLSI
S20036 A2ASS6 −0.211545 0 2 1 0.999133 Class 1 EVAWTKDKDATDLTRSPRVKIDTSAESSKFS
S9144 A2ASS6 −0.203903 0.163212 2 1 1 Class 1 NIKERLIPPSFTKKLSETVEETEGNSFKLEG
S22416 A2ASS6 −0.192457 0 2 1 0.999998 Class 1 EKKGLRWVRATKTPVSDLRCKVTGLQEGNTY
S30939 A2ASS6 −0.186488 0 2 1 0.998923 Class 1 VKVLDSPGPCGKLTVSRVTEEKCTLAWSLPQ
S18535 A2ASS6 −0.184072 0 3 1 1 Class 1 NTVSLTWNPPKYDGGSEIINYVLESRLIGTE
T266 A2ASS6 −0.174257 0.297613 2 1 1 Class 1 KTPPRIPPKPKSRSPTPPSIAAKAQLARQQS
S4175 A2ASS6 −0.168399 0.396358 3 1 1 Class 1 HEEDKIDVQGGRDHLSDAQKVETVIEAEADS
T23981 A2ASS6 −0.166376 0 3 1 0.5 Class 2 PAVTWHKDDIPLKQTTRVNAESTENNSLLTI
T14268 A2ASS6 −0.16409 0.087451 2 1 0.99985 Class 1 VFTKNLANLEVSEGDTIKLVCEVSKPGAEVI
S1529 A2ASS6 −0.159512 0.439196 3 1 0.943823 Class 1 KEDGTQSLIIVPASPSDSGEWTVVAQNRAGK
S9459 A2ASS6 −0.158813 0.124587 3 1 1 Class 1 DLRAMLKKTPALKKGSGEEEEIDIMELLKNV
T30575 A2ASS6 −0.154592 0 3 1 0.788648 Class 1 TEITNYIVEKRESGTTAWQLINSSVKRTQIK
S28281 A2ASS6 −0.146693 0.305079 3 1 0.999999 Class 1 DMKNFPSHTVYVRAGSNLKVDIPISGKPLPK
S26695 A2ASS6 −0.140014 0.346765 3 1 0.797368 Class 1 EPVIACNPYKRPGPPSTPEASAITKDSMVLT
S24391 A2ASS6 −0.137242 0.088548 2 1 0.993652 Class 1 TARLEIKSTDFATSLSVKDAVRVDSGNYILK
T29649 A2ASS6 −0.134127 0.58377 3 1 0.997724 Class 1 PSKFTLAVSPVDPPGTPDYIDVTRETITLKW
(Continued)
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T21731 A2ASS6 −0.127027 0 2 1 0.718367 Class 2 NKWQRVMKSLSLQYSTKDLKEGKEYTFRVSA
T33772 A2ASS6 −0.120166 0.177658 2 1 1 Class 1 RMPYEVPEPRRFKQATVEEDQRIKQFVPMSD
S16477 A2ASS6 −0.120059 0.290657 2 1 0.960016 Class 1 KAVDPIDAPKVILRTSLEVKRGDEIALDATI
T25842 A2ASS6 −0.117083 0 2 1 0.999999 Class 1 AGGSARIHIPFKGRPTPEITWSKEEGEFTDK
S17015 A2ASS6 −0.116476 0 3 1 0.999637 Class 1 KMCLLNWSDPADDGGSDITGFIIERKDAKMH
S3827 A2ASS6-3 −0.110284 0.69199 2 1 1 Class 1 SNEEVHGYKSRGICESPDKVSQVLTPYPSES
S34488 A2ASS6 −0.108085 0.264442 2 1 0.999994 Class 1 RVKSPEPVTSHPKAVSPTETKPTEKGQHLPV
S790 A2ASS6 −0.10482 0 3 1 0.790373 Class 1 ETHIKTTDQMGMHISSQVKKTTDISTERLVH
T26696 A2ASS6 −0.0857946 0.182593 3 1 0.989467 Class 1 PVIACNPYKRPGPPSTPEASAITKDSMVLTW
S1977 A2ASS6 −0.081692 0.055874 2 1 0.990373 Class 1 KLQFEVQKVDRPVDTSETKEVVKLKRAERIT
S19447 A2ASS6 −0.0663668 0 2 1 0.591546 Class 2 KQDTRKGTWGVVSAGSSKLKLKVPHLQKGCE
S13204 A2ASS6 −0.0662166 0.089154 2 1 0.880947 Class 1 LKPIEDVTIYEKESASFDAEISEEDIPGEWK
S25920 A2ASS6 −0.0488367 0.044418 3 1 1 Class 1 PGPPQNLAVKEVRKDSVLLVWEPPIIDGGAK
S22804 A2ASS6 −0.0380723 0.014722 2 1 0.805129 Class 1 VIEAQRKGSDQWTHISTVKGLECVVRNLTEG
S34611 A2ASS6 −0.0345249 0 2 1 0.68296 Class2 TGQSFKSIHEQVSSISETTKSVQKTAESAEA
S30572 A2ASS6 −0.0335397 0 2 1 0.832922 Class 1 DGGTEITNYIVEKRESGTTAWQLINSSVKRT
S35063 A2ASS6 −0.0245479 0 2 1 0.632417 Class2 KQEASFSSFSSSSASSMTEMKFASMSAQSMS
S4018 A2ASS6 −0.018641 0 2 1 0.675564 Class 2 VLLKEEQSEVVAVPTSQTSKSEKEPEAIKGV
S35036 A2ASS6 −0.0161605 0 2 1 0.952755 Class 1 REVVLKTSSDVSLHGSVSSQSVQMSASKQEA
S3991 A2ASS6 −0.0149712 0.0107483 2 1 0.999502 Class 1 KSTGQDVALRTEEGKSLSFPLALEEKQVLLK
S17113 A2ASS6 −0.01187 0.0154739 3 1 0.985972 Class 1 STITLDWKEPRSDGGSPIQGYIIEKRRHDKP
S814 A2ASS6 −0.0108688 0.0162498 2 1 0.999999 Class 1 STERLVHVDKRPRTASPHFTVSKISVPKTEH
S20755 A2ASS6 −0.0093163 0.0181907 2 1 1 Class 1 DGSSVLIIKDVTRKDSGYYSLTAENSSGSDT
S27556 A2ASS6 −0.0092088 0.0073245 2 1 0.999755 Class 1 DQRYEFRVFARNAADSVSEPSESTGPITVKD
S3870 A2ASS6 −0.0051650 0.0056415 3 1 0.991661 Class 1 EPEGVFPGASSAAQVSPVTIKPLITLTAEPK
S4672 A2ASS6-3 −0.0048496 0.0087214 3 1 1 Class 1 ENGDKTFISQLKRAASEEECLEDHEMEDGPT
S28731 A2ASS6 −0.0040724 0.0043022 2 1 0.974739 Class 1 LASILIKDANRLNSGSYELKLRNAMGSASAT
S17109 A2ASS6 0.00032406 0 3 1 0.836525 Class 1 ERTKSTITLDWKEPRSDGGSPIQGYIIEKRR
S14664 A2ASS6 0.0113125 0.0110327 2 1 1 Class 1 REIKEGKKYKFEKDGSIHRLIIKDCRLEDEC
T21632 A2ASS6 0.0207359 0 2 1 0.819558 Class 1 AERKSWSTVTTECSKTSFRVSNLEEGKSYFF
S17316 A2ASS6 0.02154 0 3 1 0.980872 Class 1 ESCYLTWDAPLDNGGSEITHYIIDKRDASRK
S34623 A2ASS6 0.0307702 0.0977465 2 1 1 Class 1 SSISETTKSVQKTAESPEAKKQEPIAPESIS
S756 A2ASS6 0.0341452 0.0943439 3 1 1 Class 1 HISTTKVPEQPRRPASEPHVVPQAVKPAVIQ
S34573 A2ASS6 0.0437442 0 3 1 0.978092 Class 1 SADGTYELKIHNLSESDCGEYVCEVSGEGGT
S34571 A2ASS6 0.120101 0 2 1 0.99376 Class 1 HYSADGTYELKIHNLSESDCGEYVCEVSGEG
T32113 A2ASS6 0.130455 0 3 1 0.999962 Class 1 GISKPLKSEEPVIPKTPLNPPEPPSNPPEVL
T25315 A2ASS6 0.134102 0 3 1 1 Class 1 NSECYVARDPCDPPGTPEAIIVKRNEITLQW
S2078 A2ASS6 0.155502 0.903734 2 1 1 Class 1 GKITIPTFKPERIELSPSMEAPKIFERIQSQ
T21345 A2ASS6 0.156475 0.125556 3 1 0.999996 Class 1 PVIERTLKATGLQEGTEYEFRVTAINKAGPG
S31438 A2ASS6 0.158509 0 2 1 0.78457 Class 1 VPLVPTKLEVVDVTKSTVTLAWEKPLYDGGS
S34488 A2ASS6 0.158631 0 2 2 0.999994 Class 1 RVKSPEPVTSHPKAVSPTETKPTEKGQHLPV
S34476 A2ASS6 0.159999 0 2 2 1 Class 1 RVKSPETVKSPKRVKSPEPVTSHPKAVSPTE
S35128 A2ASS6 0.165174 0.213397 2 1 0.999984 Class 1 GRGIPPKIEALPSDISIDEGKVLTVACAFTG
S315 A2ASS6 0.166903 0.183848 2 2 0.997856 Class 1 PSPVRSVSPAGRISTSPIRSVKSPLLIRKTQ
S22797 A2ASS6 0.170233 0.274145 2 1 1 Class 1 GSKITGYVIEAQRKGSDQWTHISTVKGLECV
S25870 A2ASS6 0.199285 0 2 1 1 Class 1 TDKVQIEKGINFTQLSIDNCDRNDAGKYILK
S13764 A2ASS6 0.200173 0 2 1 1 Class 1 SWFKNDQRLHTSKRVSMHDEGKTHSITFKDL
S814 A2ASS6 0.200474 0.566341 2 2 0.999999 Class 1 STERLVHVDKRPRTASPHFTVSKISVPKTEH
(Continued)
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S21152 A2ASS6 0.207222 0.196717 2 1 1 Class 1 RNLCTLELFSVNRKDSGDYTITAENSSGSKS
S307 A2ASS6 0.21303 0.565178 2 1 1 Class 1 VRHVRAPTPSPVRSVSPAGRISTSPIRSVKS
S2078 A2ASS6 0.216232 0.446394 2 2 1 Class 1 GKITIPTFKPERIELSPSMEAPKIFERIQSQ
S2080 A2ASS6 0.216232 0.446394 2 2 1 Class 1 ITIPTFKPERIELSPSMEAPKIFERIQSQTV
S33353 A2ASS6 0.219718 0.237812 3 1 1 Class 1 IRSQRGVSVAKVKVASIEIGPVSGQIMHAIG
T812 A2ASS6 0.223205 0.643762 4 2 0.999999 Class 1 DISTERLVHVDKRPRTASPHFTVSKISVPKT
Y33436 A2ASS6 0.229236 0 2 1 0.996224 Class 1 TKFDDGTYRCKVVNDYGEDSSYAELFVKGVR
S264 A2ASS6 0.246749 0.784633 2 1 1 Class 1 PHKTPPRIPPKPKSRSPTPPSIAAKAQLARQ
S3676 A2ASS6 0.258327 0 4 1 0.878152 Class 1 EDMPLYTSVCYTIIHSPDGSGTFIVNDPQRG
S879 A2ASS6 0.26138 0.407205 3 1 0.998042 Class 1 TVKPGETRVRAEPTPSPQFPFADMPPPDTYK
S1214 A2ASS6 0.287447 0.235319 2 1 1 Class 1 IQEPKVGEIAPGFAYSEYEKEYEKEQALIRK
S322 A2ASS6 0.325277 3.06343 2 1 1 Class 1 SPAGRISTSPIRSVKSPLLIRKTQTTTMATG
S12678 A2ASS6 0.331543 0.65471 3 1 1 Class 1 IEKPKLKPRPPARPPSPPKEDVKEKMFQLKA
T266 A2ASS6 0.332311 0.771702 2 2 1 Class 1 KTPPRIPPKPKSRSPTPPSIAAKAQLARQQS
S2032 A2ASS6 0.353204 0.75905 2 1 1 Class 1 EAITAVELKSRKKDESYEELLKKTKDELLHW
Novex-3 (A2ASS6-3).
Z-disk.
Proximal Ig region.
N2B-element.
Middle Ig region.
PEVK.
Distal Ig domains.
A-band.
M-band.
represent a significant change in cKO vs. WT, ten significantly
altered titin phosphorylation sites could be identified in cKO
hearts (Table 1). We identified 24 phosphosites in the elastic
spring region of titin (see Table 2). Most of them were located
in the N2B-element, PEVK region and distal Ig region. In total,
hypophosphorylation (log2 ratio cKO/WT<−0.37) was seen
in 133 titin phosphopeptides, the majority of which originated
from A- and M-band titin (see Table 3). Furthermore, 25 titin
phosphosites were hyperphosphorylated (log2 ratio cKO/WT
>0.37; Table 4). One hundred and twelve titin phosphopeptides
showed no significant differences in phosphorylation in cKO
compared to WT (−0.37> cKO/ WT ratio<+0.37; see Table 5).
Titin Isoform Composition in PKD1
cKO Mice
To study whether PKD has an influence on titin isoform
composition, homogenized myocardial samples of cKO and
matched WT mice were separated using SDS-PAGE, the protein
bands visualized by Coomassie staining and the two cardiac
titin isoforms N2BA and N2B analyzed using densitometry;
a representative titin gel showing these two isoforms in WT
and cKO is shown in Figure 2C. On average, titin isoform
composition remained unchanged in cKO vs. WT mouse hearts.
For both groups, the ratio of N2B to N2BA was ∼85:15%
(Figure 2B). A “T2” titin degradation band was also detectable
in hearts of both cKO andWT, but showed no significant change.
Site-Specific Phosphorylation at
Titin-N2Bus and Titin-PEVK
To confirm titin phosphorylation sites identified by quantitative
MS and to analyse site-specific titin phosphorylation,
affinity-purified anti-phosphosite-specific antibodies were
generated against conserved serines of human/mouse N2Bus
at Ser4010/Ser3991, Ser4062/Ser4043, and Ser4099/Ser4080,
as well as human/mouse PEVK at Ser11878/Ser12742 and
Ser12022/Ser12884. The PVDF staining served as a protein
loading control.
Using the titin anti-phospho-antibodies we found unaltered
phosphorylation at the positions Ser3991 (Figure 2C) and
Ser4080 (Figure 2E) but significantly increased phosphorylation
at the positions Ser4043 (Figure 2D), Ser12742 (Figure 2F), and
Ser12884 (Figure 2G) in cKO compared to WT hearts. Using an
anti-phosphor-Ser/Thr antibody, overall-titin phosphorylation
was found to be greatly decreased, by ≈25% on average, in cKO
compared to WT hearts (Figure 2H).
Cardiomyocyte FPassive Is Elevated in cKO
Hearts
The passive length–tension relationship of single skinned
cardiomyocytes in relaxing solution was steeper in
cKO than in WT hearts (Figures 3A,B). Significantly
increased Fpassive levels in cKO vs. WT cells were found at
sarcomere lengths (SL) of 2.1µm or higher. Administering
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FIGURE 3 | Cardiomyocyte passive stiffness and overall-titin phosphorylation in WT and PKD1 cKO mice by back-phosphorylation. (A) Representative image (left)
and stretch protocol (right) used in the experiments (B) Original recordings of the force response to stepwise cell stretching of isolated skinned cardiomyocytes. (C)
WT and PKD1 cKO Fpassive at sarcomere length 1.8–2.4µm in the presence or absence of in vitro PKD1 (16–20 cardiomyocytes/group). Curves are second-order
polynomial fits to the means (± SEM; n = 4 cardiomyocytes/heart). For B; *P < 0.05 WT vs. cKO, †P < 0.05 cKO vs. cKO after PKD treatment in Student t-test. (D)
Representative immunoblot and graph before (–PKD1) and after incubation with protein kinase D1 (+PKD1). Data are means ± SEM; n = 4 hearts/group. Each heart
was analyzed in duplicate. *P < 0.05 in Students unpaired and paired t-test.
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FIGURE 4 | Myocardial oxidative stress parameters, PKD-content and phosphorylation, and HSP27-content and phosphorylation in HCM patients. (A) Reduced
Glutathione (GSH). (B) Hydrogen Peroxide (H2O2 ). (C) Protein Kinase D (PKD). (D) Phospho-Ser916 PKD. (E) Representative blots of (Phospho)PKD and GAPDH. (F)
Heat Shock Protein 27 (HSP27). (G) Phospho-monomer HSP27. (H) Phospho-dimer HSP27. (I) Representative blots of HSP27 and monomer and dimer of HSP27.
Data are means ± SEM; n = 7–8 hearts/group.
PKD to non-activated skinned cardiomyocytes from
cKO hearts in relaxing solution significantly reduced
Fpassive at SL 2.2µm or higher, returning it to levels
found in matched WT cells (Figure 3C), whereas
administration of PKD to WT cardiomyocytes did not
affect Fpassive.
In an alternative approach, demembranated cardiac fiber
bundles from hearts of these mice were phosphorylated ex vivo
by PKD and then titin SDS-PAGE was performed followed by
Western blot analysis. Titin phosphorylation was significantly
increased after PKD treatment in cKO hearts, while in WT it
remained unaltered (Figure 3D).
Increased PKD and HSP27 Activity Is
Associated With Increased Oxidative
Stress
In HCM hearts, we found less reduced glutathione (GSH) and
increased hydrogen peroxide (H2O2), both of which indicate
that oxidative stress was increased in HCM hearts compared
to control non-failing hearts (Figures 4A,B). Myocardial PKD
content and PKD phosphorylation at phosphosite Ser916
were both significantly higher in HCM hearts compared to
controls, indicating total myocardial PKD activity in HCM
(Figures 4C–E). In addition, the amount of HSP27 was
higher in hearts of HCM patients compared to controls
(Figure 4F) and the phosphorylation of HSP27 resulted in an
altered dimer phosphorylation of HSP27 in HCM compared
to controls, while HSP27 monomers remained unchanged
(Figures 4G–I).
Cardiomyocyte FPassive Is Elevated in HCM
Hearts
Cardiomyocytes from human end-stage failing hearts (only
from patients with hypertrophic cardiomyopathy) showed a
higher cardiomyocyte Fpassive at sarcomere length 2.1µm
or higher compared to non-failing human heart samples.
Administering human recombinant PKD to non-activated
skinned cardiomyocytes from human HCM hearts in relaxing
solution significantly reduced Fpassive at sarcomere length 2.1µm
or higher, lowering it to levels found in cells from control
hearts (Figures 5A–C). In addition, upon treatment with human
recombinant HSP27, Fpassive was significantly reduced at all
sarcomere lengths, whereas control cardiomyocytes remained
unaltered (Figures 5D,E).
Titin Phosphorylation in Hearts of Human
HCM Patients
We found increased CaMKII phosphosites at titin positions
Ser4062 and Ser12022 in HCM compared to control hearts
(Figures 6A,B), which went along with increased myocardial
CaMKII content and activity (Figures 6C,D). Total titin
phosphorylation was significantly lower in HCM compared to
non-failing hearts (Figure 6E). Using an alternative approach,
we measured total titin phosphorylation in demembranated
cardiac fiber bundles obtained from HCM and non-failing
human hearts before and after ex vivo phosphorylation
by human recombinant PKD (Figure 6E). Strong signals
were seen for both isoforms N2BA and N2B after kinase
treatment, and the total phosphorylation of titin was significantly
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FIGURE 5 | Cardiomyocyte passive stiffness in human non-failing and failing HCM hearts. (A) Stretch protocol used in experiments. (B) Fpassive at sarcomere length
1.8–2.4µm in the presence or absence of in vitro human recombinant PKD of human non-failing control and failing HCM. (C) Original recordings of the force response
to stepwise cell stretching of isolated skinned cardiomyocytes. Curves are second-order polynomial fits to the means (± SEM; n = 4 cardiomyocytes/heart). For (B);
*P < 0.05 Control vs. HCM, †P < 0.05 HCM vs. HCM after PKD or HSP27 treatment in Student t-test. (D) Human non-failing control and failing HCM Fpassive at
sarcomere length 1.8–2.4µm in the presence or absence of in vitro human recombinant HSP27. (E) Original recordings of the force response to stepwise cell
stretching of isolated skinned cardiomyocytes.
increased by more than 20% in non-failing and failing
HCM hearts.
Subcellular Localization and Overlay of
PKD and HSP27 in HCM and Control Hearts
As we found a relatively high level of PKD expression in
failing HCM hearts using western blot, we wished to determine
the cellular distribution of PKD using confocal laser scanning
and electron microscopy. The confocal images showed a
clear overlay of PKD signals with sarcomeres in control and
HCM hearts (Figure 7A). Phospho-HSP27 was clearly present
at the periphery of the cardiomyocytes in HCM compared
to control hearts, whereas in control hearts, phospho-HSP27
was distributed throughout the cardiomyocyte (Figure 7B).
2D intensity histograms show two channels and the level
of overlapping. For a high overlapping level, the histogram
pixels tend to concentrate more along the y = x line. 2D
intensity histogram analysis showed a more intense presence of
PKD in HCM but distribution was not significantly different,
while phospho-HSP27 in HCM hearts compared to controls
showed less correlation with α-actinin as more pixels concentrate
at the axis of the histogram, the less correlation can be
expected (Figures 7C,D). In keeping with these findings, electron
microscopy confirmed the higher level of PKD in myocardium
HCM compared to control hearts (Figures 8A,B). Using electron
microscopy, HSP27 showed a strongly altered localization away
from the Z-disk and A-band in HCM, whereas HSP27 was
located preferentially at the Z-disk and A-band in controls
(Figures 8C,D).
DISCUSSION
PKD has emerged as a key regulator of excitation-contraction
coupling and cardiac hypertrophic signaling. Cardiac-specific
PKD1-cKO mice show resistance to cardiac hypertrophy and
fibrosis in response to pressure overload and angiotensin II
treatment (Fielitz et al., 2008). Overexpression of constitutively
active PKD1 in mouse hearts leads to dilated cardiomyopathy,
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FIGURE 6 | Titin phosphorylation and CaMKII content and activity in hearts of failing HCM and non-failing control patients. (A) Site-specific phosphorylation at position
Ser4062 in N2Bus (n = 8− 10 hearts/group; each heart analysed in duplicate). (B) Site specific phosphorylation at position Ser12022 in PEVK region (n = 8− 10
hearts/group; each heart analysed in duplicate). (C) CaMKII content in HCM vs. control hearts (n = 9 hearts/group). or absence of in vitro PKD. (D) CaMKII
(Continued)
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FIGURE 6 | activity in HCM vs. control hearts (n = 9 hearts/group). (E) Total N2B-titin phosphorylation in HCM vs. control hearts (n = 8− 10 hearts/group; each heart
analysed in duplicate). Representative immunoblot right panel and graph left panel before (–PKD) and after incubation with protein kinase D1 (+PKD). Data are means
± SEM; n = 6 hearts/group. Each heart was analyzed in duplicate. *P < 0.05 vs. Control untreated; †P < 0.05 vs. HCM untreated.
and an increase in PKD1 expression and activity is seen in
failing hearts of rats (Harrison et al., 2006), rabbits and humans
(Bossuyt et al., 2008). These findings indicate the importance of
PKD1 in regulating cardiac pathophysiology and the potential
of the kinase as a therapeutic target in cardiovascular disease
(Nichols et al., 2014). As PKD1 showed some beneficial effects
on cardiomyocyte function (Haworth et al., 2004; Cuello et al.,
2007), we wanted to know if PKD is also involved in the
phosphorylation of titin. We demonstrated that titin is an
important substrate of PKD. In a quantitative MS screen
using PKD1-cKO hearts and the SILAC mouse heart, we
found that titin was among the cardiac proteins most highly
affected by PKD1 deletion. Overall, titin phosphorylation was
significantly reduced in cKO compared to WT hearts. Many
of the phosphosites found in titin are located within the Z-
disk, A-band, or M-band sections of the molecule, where they
could be involved in regulating protein–protein interactions
or mechanical signaling (Figure 9). In addition, we identified
many phosphosites within the I-band titin region (proximal Ig
region, N2-Bus and PEVK region) present in the N2BA and N2B
cardiac titin isoforms (Figure 9). Furthermore, we showed that
PKD reduces cardiomyocyte stiffness in PKD1 cKO mice and in
failing hearts of human HCM patients. As PKD1 activation and
increased PKD1 phosphorylation is observed in the hypertrophic
heart from mice that have undergone tac surgery and as
PKD plays an important role in the development of cardiac
hypertrophy as shown via inhibition of hypertrophy in isolated
neonatal cardiomyocytes from Wistar rats with PKD deletion
(Zhao et al., 2017, 2019), we used human HCM tissues to validate
how important is PKD in human heart failure with hypertrophy.
We found disturbed titin phosphorylation in human HCM
hearts, possibly contributing to the mechanical dysfunction. This
was associated with increased PKD and CaMKII content and
activity in these hearts. Moreover, we detected an increased
amount and phosphorylation of HSP27, a substrate of PKD,
in human HCM hearts. Changes in PKD, CaMKII and HSP27
were associated with increased oxidative stress parameters. Our
work reveals a previously unknown role of PKD in regulating
diastolic passive properties of healthy and diseased hearts, and
its association with oxidative stress and changes affecting HSP27.
Titin Is a Substrate of PKD
Changes in titin stiffness due to isoform switching or post-
translational modifications such as phosphorylation and
oxidation have been reported in a variety of species. Previous
studies showed that heart failure is associated with a chronic
deficit in global titin phosphorylation (Bishu et al., 2011;
Falcao-Pires et al., 2011; Hamdani et al., 2013a,b). Titin is
phosphorylated by PKA at the N2B spring element, which results
in a reduction of cardiomyocyte Fpassive (Yamasaki et al., 2002;
Kruger and Linke, 2006). In addition, titin is phosphorylated by
PKG at the N2Bus (Kruger et al., 2009; Kotter et al., 2013), a
modification that also reduces cardiomyocyte Fpassive (Borbely
et al., 2009; Hamdani et al., 2013a, 2014). Following short-
term cGMP-enhancing treatment with sildenafil and B-type
natriuretic peptide (BNP) in an animal model of heart failure
with preserved ejection fraction (HFpEF) (elderly hypertensive
dogs) (Bishu et al., 2011), PKG-mediated phosphorylation
of titin resulted in acutely increased cardiac extensibility and
may also positively regulate hypertrophic signaling. Our study
provides the first evidence that PKD also phosphorylates titin.
Notably, altered phosphorylation of titin sites was seen within
the PEVK-domain, especially at the phosphosites that are also
CaMKII-dependent. Perhaps this hints at a compensatory
mechanism due to the loss of PKD in these mice.
Cardiomyocyte Stiffness and PKD
Cardiomyocyte Fpassive was elevated in cKO compared to
WT, and incubating skinned cardiomyocytes with PKD
lowered Fpassive in cKO, but did not affect WTs. Furthermore,
cardiomyocyte isolated from failing HCM hearts showed
increased Fpassive, which could be reduced upon treatment with
PKD enzyme. Thus, PKD alters Fpassive in the same direction
as PKA, PKG, ERK2, and CaMKIIδ, an effect that may depend
mainly on the phosphorylation of N2Bus. The latter increases the
persistence length of N2Bus and thereby reduces Fpassive (Kruger
et al., 2009). Another possible mechanism is via phosphorylation
of titin Ig domains, although this is not yet proven. To date,
PKCα is the only kinase that increases cardiomyocyte stiffness
via phosphorylation of the PEVK region. The mechanical effect
of PKCα-mediated PEVK phosphorylation includes increased
persistence length of PEVK causing increased stretch-dependent
force of the titin spring, thus elevating cardiomyocyte passive
tension (Hidalgo et al., 2009). Reduced all-titin phosphorylation
contribute to the development of heart failure, against the
reduced phosphorylation, increased phosphorylation has
been demonstrated in heart failure, the PKCα-dependent
phosphosite at S11878 within the PEVK-titin segment was
hyperphosphorylated in HFpEF animal models (Hamdani et al.,
2013a, 2014; Linke and Hamdani, 2014; Franssen et al., 2016).
PKCα was shown to be increased in heart failure (Belin et al.,
2007) and in the HFpEF dog hearts. We believe what might
determine the spatial arrangement phosphorylation along the
titinmolecule is the distinct micro-environment of phospho-sites
either surrounded by negatively charged micro-environment
and phospho-sites located at hydrophobic environment and
close to cysteines sites. This may induce distinct biological and
mechanical responses that may have differential effects on heart
muscle exposed to oxidative stress and inflammation.
In failing human hearts, the activities of PKA and PKG
are typically reduced (Hamdani et al., 2013a, 2014; Linke and
Hamdani, 2014; Franssen et al., 2016), whereas the activity
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FIGURE 7 | Images of confocal laser scanning microscopy of PKD or HSP27 in human cardiomyocytes from failing HCM and control hearts. (A) Representative
immunohistochemistry of PKD labeling in non-failing control human biopsy specimens along with a volume view. (B) Representative immunohistochemistry of PKD
labeling in HCM human biopsy specimens along with a volume view. (C) 2D intensity histograms showing the relationship of intensities at the exact position between
two channels representing alpha-actinin and PKD. (D) 2D intensity histograms showing the relationship of intensities at the exact position between two channels
representing HSP-27 and alpha-actinin.
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FIGURE 8 | Electron microscopy images to illustrate sarcomeric localization of PKD and HSP27 in human cardiomyocytes of failing HCM and non-failing control
hearts. (A) Representative electron microscopy images with PKD labeling in non-failing control human. (B) Representative electron microscopy images with PKD
labeling in HCM. (C) Representative electron microscopy images with HSP27 labeling in non-failing control human. (D) Representative electron microscopy images
with HSP27 labeling in HCM. Small red arrow is for monomer; arrowhead red is for dimer; and big red arrow is for polymer.
FIGURE 9 | Overview of identified phosphosites on the entire titin molecule Figure shows all detected phosphosites on the Z-disk, Proximal Ig region, N2B-element,
Middle Ig region, PEVK, Distal Ig domains, A-band, and M-band. Upregulated, downregulated, and unchanged.
and the expression of PKCα, ERK2, and CaMKIIδ are usually
increased, perhaps because of the presence of hypertrophy.
In human failing HCM hearts, cardiomyocyte Fpassive was
increased compared to non-failing hearts, an effect that was
related to increased CaMKII activity and consequently, increased
phosphorylation of titin within the PEVK region at CaMKIIδ-
dependent phosphosites (Bishu et al., 2011; Falcao-Pires et al.,
2011; Hamdani et al., 2013a,b). Cardiomyocyte Fpassive has been
found to be pathologically elevated in human HFpEF and heart
failure with reduced ejection fraction (HFrEF), due to disturbed
activity of PKA and PKG. While inhibition of PKCα activity has
been suggested as a potential therapeutic target for hypertrophied
hearts, boosting PKD enzyme activity in failing, overly stiff,
hearts could be beneficial for cardiomyocyte stiffness, similar to
PKA, PKG, and ERK2 (Borbely et al., 2009; Raskin et al., 2012;
van Heerebeek et al., 2012; Hamdani et al., 2013a, 2014; Kotter
et al., 2013; Linke and Hamdani, 2014). A reduction in PKD-
mediated titin phosphorylation, in turn, would increase Fpassive
and be detrimental to diastolic filling. However, a stiffer titin
spring could speed up diastolic recoil and amplify some of the
mechanosensory functions of titin.
The PKD Substrate HSP27
The current study also showed that HSP27 content and
phosphorylation is increased in human HCM hearts, a
mechanism that might work to protect cardiomyocytes from
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damage, as an established function of HSP27 is to prevent stress-
induced protein aggregation and myocardial damage (Linke
and Hamdani, 2014). The observed increase in HSP27 was
associated with increased oxidative stress and increased content
and activity of PKD, which also phosphorylates HSP27. PKD
showed a polymer formation on EM, which indicates that PKD
is oxidized. This may thus explain the beneficial ex-vivo effect
of PKD on cardiomyocyte Fpassive and indicates that perhaps
increased PKD activity observed in HCM hearts is partially
due to PKD oxidation as well-suggesting that by lowering
oxidation we may improve cardiomyocyte function in a manner
similar to administration of endogenous PKD ex vivo. PKD
is an important downstream regulator of the oxidative stress
response, and increased oxidative stress leads to the activation
of different PKD isoforms and subsequent phosphorylation
of HSP27 (Doppler et al., 2005; Stetler et al., 2012). In our
study, phosphorylation of HSP27 was increased in HCM hearts,
which is in line with previous findings showing that HSP27
phosphorylation prevents apoptosis by protecting cells against
heat shock, apoptosis effectors, oxidative stress, and ischemia
(Martin et al., 1997; Benjamin and McMillan, 1998; Knowlton
et al., 1998; Yoshida et al., 1999; Dohke et al., 2006; Li et al., 2012).
HSP27 is abundant in cardiac muscle cells, commonly localized
to the Z-disk and I-band regions of the sarcomere, and involved
in the protection of titin and intermediate filaments (Kotter et al.,
2014; Linke and Hamdani, 2014). In HCM hearts, HSP27 showed
a strongly altered localization away from the Z-disk and I-band,
whereas in non-failing hearts, HSP27 was preferentially localized
to the Z-disk and I-band. Whether the translocation of HSP27
depends on the altered phosphorylation status of HSP27 is still
controversial (Mymrikov et al., 2011); altered phosphorylation of
HSP27 at least did not alter the binding to titin domains (Kotter
et al., 2014; Linke and Hamdani, 2014). HSP27 can function as an
inhibitor of cell death upon its phosphorylation and dissociation
to lower-molecular-weight oligomers, while the presence of
the high-molecular-weight, non-phosphorylated form of HSP27
appears to be necessary for cellular protection against cardiac
ischemia/reperfusion (Golenhofen et al., 2002, 2006; Kadono
et al., 2006; Pinz et al., 2008). PKD specifically phosphorylates
HSP27 in pancreatic cancer cells (Yuan and Rozengurt, 2008)
and endothelial cells (Evans et al., 2008). Phosphorylation of
Ser82 is considered to be the main “effector” step for the
shift from large molecular weight multimers to differentially
functional oligomers. As regards titin, HSP27 specifically protects
the unfolded Ig regions, but not the intrinsically disordered
segments (N2Bus and PEVK), from aggregating under acidic
stress (Kotter et al., 2014). The protective role of small HSPs on
titin extensibilitywas also evident in earlier studies in which α-B
crystallin lowered the persistence length of the N2Bus segment
and reduced the unfolding probability of the immunoglobulin
domains flanking the N2Bus segment (Bullard et al., 2004).
Isolated hearts lacking sHSPs (DKO) showed severe contractile
dysfunction (Pinz et al., 2008), increased myocardial injury
and resting tension (Golenhofen et al., 2006), accompanied by
diastolic dysfunction in response to ischemia/reperfusion ex vivo
(Pinz et al., 2008). This accords with our previous findings
in isolated human cardiomyocytes in which under conditions
promoting titin aggregation (pre-stretch and acidic pH), passive
stiffness was high in the absence of sHSPs but normal in the
presence of sHSPs (Kotter et al., 2014). In our present work
on human HCM cardiomyocytes, HSP27 lowered Fpassive to the
levels previously reported after administration of PKA and/or
PKG (Borbely et al., 2005; Fukuda et al., 2005; Kruger et al.,
2009; Falcao-Pires et al., 2011). In addition, Fpassive fell to the level
observed after PKD administration.
CONCLUSION
Our findings have important therapeutic implications as they
imply that drugs that balance PKD activity and restore HSP27
localization to the Z-disk and I band may show efficacy
as a treatment for diastolic LV dysfunction related to high
cardiomyocyte stiffness.
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